Join to View Full Profile
5500 Friendship BlvdChevy Chase, MD 20815
Phone+1 301-951-7142
Dr. Myrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Dorkina Myrick is a pathology specialist located in Chevy Chase, MD, with subspecialties in Anatomic Pathology and Clinical Pathology. She completed her residency at the National Institutes of Health Clinical Center and graduated from The Warren Alpert Medical School of Brown University in 2001, where she also earned her Ph.D. in Biology (Pathobiology). She is currently employed as a physician-scientist. She has authored several publications, with the most recent being "When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic," published in the Journal of Law and the Biosciences.
Education & Training
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Brown UniversityPh.D., Biology (Pathbiology), 1993 - 2001
The Warren Alpert Medical School of Brown UniversityClass of 2001
Certifications & Licensure
MD State Medical License 2004 - 2025
Publications & Presentations
PubMed
- When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic.Tomasz Ozyhar, Laura Barnabei, Dorkina Myrick
Journal of Law and the Biosciences. 2022-02-26 - 57 citationsCombined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line.Shashi Mehta, Dilshad Blackinton, Imran Omar, Nicola Kouttab, Dorkina Myrick
Cancer Chemotherapy and Pharmacology. 2000-01-01 - 37 citationsPaclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide.Dorkina Myrick, Dilshad Blackinton, Jim Klostergaard, Nicola Kouttab, Abby Maizel
Leukemia Research. 1999-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
